Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.36 - $0.61 $94,848 - $160,715
263,468 Added 145.76%
444,222 $173,000
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $66,154 - $150,502
165,387 Added 1076.25%
180,754 $95,000
Q4 2023

Feb 14, 2024

SELL
$0.71 - $0.97 $1,258 - $1,718
-1,772 Reduced 10.34%
15,367 $13,000
Q3 2023

Nov 14, 2023

BUY
$0.96 - $2.01 $16,453 - $34,449
17,139 New
17,139 $16,000
Q2 2022

Aug 15, 2022

SELL
$2.19 - $3.98 $15,822 - $28,755
-7,225 Reduced 30.57%
16,410 $41,000
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $77,522 - $168,281
23,635 New
23,635 $91,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $823M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.